Abstract
Psychopharmacological disorders are among the leading cause of non-fatal disease burden in India. One in seven Indians was affected by psychopharmacological disorders. Although psychopharmacological agents is used for the management of psychological disorders like anxiety, psychosis, depression and mania it may side effects such as tardative dyskinesia, weight gain, weight loss, muscle cramps, dysphoria, gastrointestinal upset, eye problems or problems with blood tests. In this present review we made an exposure regarding many screening methods on evaluation of psychopharmacological disorders like anxiety, depression, psychosis and mania in the aspects of preclinical studies. These methods are very useful to evaluate the psychopharmacological agents like anti-anxiety agents, anti-psychotics, anti-depressants and anti-manic agents.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
